Letter from Mike Gorman to Tony Fiskett, Merck Sharp & Dohme Research Labs
In this letter Gorman discussed items on a proposed budget for the glaucoma organization's first year, which was to be
funded by Fiskett's company, Merck, Sharp, & Dohme. His comments about the duties of an associate director, expenses
for consultants, and the costs of newsletters reveal much about the day-to-day operations of such an organization.
Item is a photocopy.
Number of Image Pages:
3 (338,874 Bytes)
1983-07-27 (July 27, 1983)
Merck Sharp & Dohme Research Labs
This item is in the public domain. It may be used without permission.
Medical Subject Headings (MeSH):
Health Care Reform
Legislation as Topic
New Campaigns: Fighting High Blood Pressure and Glaucoma, 1973-1988